Silo pharma partners with resyca for ind-supporting intranasal drug-device study of ptsd drug spc-15

Study is expected to deliver final device data and documentation needed for planned fda ind submission study is expected to deliver final device data and documentation needed for planned fda ind submission

SILO Ratings Summary

SILO Quant Ranking